Opioids, sensory systems and chronic pain

European Journal of Pharmacology

Volumn 716, Issue 1-3, 2013, Pages 179-187

  Stein, Christoph ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Addiction; Arthritis; Cancer pain; Chonic pain; Clinical applications; Dependence; Dorsal root ganglion; Inflammation; Morphine; Non malignant pain; Peripheral; Postoperative pain; Surgery; Tolerance

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; ANALGESIC AGENT; BUPRENORPHINE; BUTORPHANOL; CODEINE; FENTANYL; FENTANYL DERIVATIVE; METHADONE; MORPHINE; NALBUPHINE; NALOXONE; OPIATE ANTAGONIST; OPIATE DERIVATIVE; OPIATE RECEPTOR; PENTAZOCINE;

ADDICTION; ANALGESIA; BLEEDING; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; COGNITIVE DEFECT; CONSTIPATION; DIGESTIVE SYSTEM ULCER; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; DRUG USE; HEART INFARCTION; HUMAN; HYPERALGESIA; MUSCULOSKELETAL PAIN; NAUSEA; NEUROPATHIC PAIN; NONHUMAN; OPIATE ADDICTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SENSORY SYSTEM; SOCIAL PSYCHOLOGY;

ADDICTION; ARTHRITIS; CANCER PAIN; CHONIC PAIN; CLINICAL APPLICATIONS; DEPENDENCE; DORSAL ROOT GANGLION; INFLAMMATION; MORPHINE; NON-MALIGNANT PAIN; PERIPHERAL; POSTOPERATIVE PAIN; SURGERY; TOLERANCE;

ANALGESICS, OPIOID; ANIMALS; CHRONIC PAIN; HUMANS; NERVOUS SYSTEM;

EID: 84892575256     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.01.076     Document Type: Review

References (110)

1. American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine, 2010. Practice guidelines for chronic pain management. Anesthesiology 112, 810-833.
2. Antonijevic, I., Mousa, S.A., Schäfer, M., Stein, C., 1995. Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 15, 165-172.
3. Barasch, A., Peterson, D.E., 2003. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol. 39, 91-100.
4. Baron, R., 2006. Mechanisms of disease: neuropathic pain-a clinical perspective. Nat. Clin. Pract. Neurol. 2, 95-106.
5. Basbaum, A.I., Bautista, D.M., Scherrer, G., Julius, D., 2009. Cellular and molecular mechanisms of pain. Cell 139, 267-284.
6. Berge, O.G., 2011. Predictive validity of behavioural animal models for chronic pain. Br. J. Pharmacol. 164, 1195-1206.
7. Bigal, M.E., Rapoport, A.M., Sheftell, F.D., Tepper, S.J., Lipton, R.B., 2004. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia 24, 483-490.
8. Brack, A., Rittner, H.L., Stein, C., 2011. Immunosuppressive effects of opioids-clinical relevance. J. Neuroimmune Pharmacol. 6, 490-502.
9. Brack, A., Stein, C., Schaible, H.G., 2006. Periphere und zentrale Mechanismen des Entzündungsschmerzes. In: Straub, R.H. (Ed.), Lehrbuch der klinischen Pathophysiologie komplexer chronischer Erkrankungen. Vandenhoeck & Ruprecht, Göttingen, pp. 183-192.
10. Breivik, H., Collett, B., Ventafridda, V., Cohen, R., Gallacher, D., 2006. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain 10, 287-333.
11. Busch-Dienstfertig, M., Labuz, D., Wolfram, T., Vogel, N.N., Stein, C., 2012. JAKSTAT1/ 3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats. Mol. Pain 8, 83.
12. Carlino, E., Pollo, A., Benedetti, F., 2011. Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience. Curr. Opin. Anaesthesiol. 24, 540-544.
13. Carroll, I.R., Angst, M.S., Clark, J.D., 2004. Management of perioperative pain in patients chronically consuming opioids. Reg. Anesth. Pain Med. 29, 576-591.
14. Cayla, C., Labuz, D., Machelska, H., Bader, M., Schäfer, M., Stein, C., 2012. Impaired nociception and peripheral opioid antinociception in mice lacking both kinin B1 and B2 receptors. Anesthesiology 116, 448-457.
15. Cheng, H.Y., Pitcher, G.M., Laviolette, S.R., Whishaw, I.Q., Tong, K.I., Kockeritz, L.K., Wada, T., Joza, N.A., Crackower, M., Goncalves, J., Sarosi, I., Woodgett, J.R., Oliveira-dos-Santos, A.J., Ikura, M., van der Kooy, D., Salter, M.W., Penninger, J. M., 2002. DREAM is a critical transcriptional repressor for pain modulation. Cell 108, 31-43.
16. Collett, B.J., 1998. Opioid tolerance: the clinical perspective. Br. J. Anaesth. 81, 58-68.
17. Collin, E., Poulain, P., Gauvain-Piquard, A., Petit, G., Pichard-Leandri, E., 1993. Is disease progression the major factor in morphine 'tolerance' in cancer pain treatment? Pain 55, 319-326.
18. Compton, P., Miotto, K., Elashoff, D., 2004. Precipitated opioid withdrawal across acute physical dependence induction methods. Pharmacol. Biochem. Behav. 77, 263-268.
19. Dahan, A., van Dorp, E., Smith, T., Yassen, A., 2008. Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur. J. Pain 12, 403-411.
20. Davis, K.D., Racine, E., Collett, B., 2012. Neuroethical issues related to the use of brain imaging: can we and should we use brain imaging as a biomarker to diagnose chronic pain? Pain 153, 1555-1559.
21. Diego, L., Atayee, R., Helmons, P., Hsiao, G., von Gunten, C.F., 2011. Novel opioid antagonists for opioid-induced bowel dysfunction. Expert Opin. Invest. Drugs 20, 1047-1056.
22. Eisenberger, N.I., Lieberman, M.D., Williams, K.D., 2003. Does rejection hurt? An FMRI study of social exclusion. Science 302, 290-292.
23. Endres-Becker, J., Heppenstall, P.A., Mousa, S.A., Labuz, D., Oksche, A., Schäfer, M., Stein, C., Zöllner, C., 2007. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol. Pharmacol. 71, 12-18.
24. Engel, C.C., von Korff, M., Katon, W.J., 1996. Back pain in primary care: predictors of high health-care costs. Pain 65, 197-204.
25. Eriksen, J., Sjogren, P., Bruera, E., Ekholm, O., Rasmussen, N.K., 2006. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 125, 172-179.
26. Farley, P., 2011. Should topical opioid analgesics be regarded as effective and safe when applied to chronic cutaneous lesions? J. Pharm. Pharmacol. 63, 747-756.
27. Filizola, M., Devi, L.A., 2012. Structural biology: how opioid drugs bind to receptors. Nature 485, 314-317.
28. Fishbain, D.A., Cole, B., Lewis, J.E., Gao, J., Rosomoff, R.S., 2009. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med. 10, 829-839.
29. Flor, H., Diers, M., 2007. Limitations of pharmacotherapy: behavioral approaches to chronic pain. Handb. Exp. Pharmacol., 415-427.
30. Fordyce, W.E., 1991. Opioids and treatment targets. Am. Pain Soc. Bull. 1, 1-4.
31. Fordyce, W.E., Fowler, R.S., DeLateur, B., 1968. An application of behavior modification technique to a problem of chronic pain. Behav. Res. Ther. 6, 105-107.
32. Gatchel, R.J., Okifuji, A., 2006. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. J. Pain 7, 779-793.
33. Gustavsson, A., Bjorkman, J., Ljungcrantz, C., Rhodin, A., Rivano-Fischer, M., Sjolund, K.F., Mannheimer, C., 2012. Pharmaceutical treatment patterns for patients with a diagnosis related to chronic pain initiating a slow-release strong opioid treatment in Sweden. Pain 153, 2325-2331.
34. Hadi, I., Morley-Forster, P.K., Dain, S., Horrill, K., Moulin, D.E., 2006. Brief review: perioperative management of the patient with chronic non-cancer pain. Can. J. Anaesth. 53, 1190-1199.
35. Hassan, A.H.S., Ableitner, A., Stein, C., Herz, A., 1993. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55, 185-195.
36. Herz, A., Millan, M.J., Stein, C., 1989. Arthritic inflammation in rats as a model of chronic pain: role of opioid systems. NIDA Res. Monogr. 95, 110-115.
37. Hojsted, J., Sjogren, P., 2007. Addiction to opioids in chronic pain patients: a literature review. Eur. J. Pain 11, 490-518.
38. Holzer, P., 2009. Opioid receptors in the gastrointestinal tract. Regul. Pept. 155, 11-17.
39. Jacobson, L., Mariano, A.J., Chabal, C., Chaney, E.F., 1997. Beyond the needle: expanding the role of anesthesiologists in the management of chronic nonmalignant pain. Anesthesiology 87, 1210-1218.
40. Jensen, M.P., Nielson, W.R., Kerns, R.D., 2003. Toward the development of a motivational model of pain self-management. J. Pain 4, 477-492.
41. Kager, I., Mousa, S.A., Sieper, J., Stein, C., Pipam, W., Likar, R., 2011. Blockade of intra-articular adrenergic receptors increases analgesic demands for pain relief after knee surgery. Rheumatol. Int. 31, 1299-1306.
42. Kalso, E., Smith, L., McQuay, H.J., Moore, R.A., 2002. No pain, no gain: clinical excellence and scientific rigour-lessons learned from IA morphine. Pain 98, 269-275.
43. Labuz, D., Schmidt, Y., Schreiter, A., Rittner, H.L., Mousa, S.A., Machelska, H., 2009. Immune cell-derived opioids protect against neuropathic pain in mice. J. Clin. Invest. 119, 278-286.
44. Langley, P.C., 2011. The prevalence, correlates and treatment of pain in the European Union. Curr. Med. Res. Opin. 27, 463-480.
45. Lee, M.C., Wanigasekera, V., Tracey, I., 2012. Imaging opioid analgesia in the human brain. Trends Anaesth. Crit. Care 2, 244-248.
46. Likar, R., Mousa, S.A., Philippitsch, G., Steinkellner, H., Koppert,W., Stein, C., Schäfer, M., 2004. Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia. Br. J. Anaesth. 93, 375-380.
47. Likar, R., Mousa, S.A., Steinkellner, H., Koppert,W., Philippitsch, G., Stein, C., Schäfer, M., 2007. Involvement of intra-articular corticotropin-releasing hormone in postoperative pain modulation. Clin. J. Pain 23, 136-142.
48. Loeser, J.D., Treede, R.D., 2008. The Kyoto protocol of IASP Basic Pain Terminology. Pain 137, 473-477.
49. Machelska, H., Schroff, M., Oswald, D., Binder, W., Sitte, N., Mousa, S.A., Rittner, H.L., Brack, A., Labuz, D., Busch, M., Wittig, B., Schäfer, M., Stein, C., 2009. Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain. Mol. Pain 5, 72.
50. Martell, B.A., O'Connor, P.G., Kerns, R.D., Becker, W.C., Morales, K.H., Kosten, T.R., Fiellin, D.A., 2007. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann. Intern. Med. 146, 116-127.
51. McNicol, E., 2008. Opioid side effects and their treatment in patients with chronic cancer and noncancer pain. J Pain Palliat. Care Pharmacother. 22, 270-281.
52. Millan, M.J., 2002. Descending control of pain. Prog. Neurobiol. 66, 355-474.
53. Mogil, J.S., Davis, K.D., Derbyshire, S.W., 2010. The necessity of animal models in pain research. Pain 151, 12-17.
54. Moshourab, R., Stein, C., 2012. Fentanyl decreases discharges of C and A nociceptors to suprathreshold mechanical stimulation in chronic inflammation. J. Neurophysiol. 108, 2827-2836.
55. Mousa, S.A., Cheppudira, B.P., Shaqura, M., Fischer, O., Hofmann, J., Hellweg, R., Schafer, M., 2007a. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 130, 502-513.
56. Mousa, S.A., Shakibaei, M., Sitte, N., Schäfer, M., Stein, C., 2004. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145, 1331-1341.
57. Mousa, S.A., Straub, R.H., Schäfer, M., Stein, C., 2007b. Beta-endorphin, Metenkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann. Rheum. Dis. 66, 871-879.
58. Noble, M., Treadwell, J.R., Tregear, S.J., Coates, V.H., Wiffen, P.J., Akafomo, C., Schoelles, K.M., 2010. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst. Rev., CD006605.
59. Obara, I., Makuch, W., Spetea, M., Schutz, J., Schmidhammer, H., Przewlocki, R., Przewlocka, B., 2007. Local peripheral antinociceptive effects of 14-Omethyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur. J. Pharmacol. 558, 60-67.
60. Obara, I., Parkitna, J.R., Korostynski, M., Makuch, W., Kaminska, D., Przewlocka, B., Przewlocki, R., 2009. Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141, 283-291.
61. Paulozzi, L., Baldwin, G., Franklin, G., Kerlikowske, R.G., Jones, C.M., Ghiya, N., Popovic, T., 2012. CDC grand rounds: prescription drug overdoses-a U.S. epidemic. Morb. Mortal. Wkly. Rep. 61, 10-13.
62. Picard, P.R., Tramer, M.R., McQuay, H.J., Moore, R.A., 1997. Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 72, 309-318.
63. Pizzo, P.A., Clark, N.M., 2012. Alleviating suffering 101-pain relief in the United States. N. Engl. J. Med. 366, 197-199.
64. Pühler, W., Zöllner, C., Brack, A., Shaqura, M.A., Krause, H., Schäfer, M., Stein, C., 2004. Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129, 473-479.
65. Raja, S.N., 2012. Modulating pain in the periphery: gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010. Reg. Anesth. Pain Med. 37, 210-214.
66. Richebe, P., Beaulieu, P., 2009. Perioperative pain management in the patient treated with opioids: continuing professional development. Can. J. Anaesth. 56, 969-981.
67. Rittner, H.L., Amasheh, S., Moshourab, R., Hackel, D., Yamdeu, R.S., Mousa, S.A., Fromm, M., Stein, C., Brack, A., 2012. Modulation of Tight Junction Proteins in the Perineurium to Facilitate Peripheral Opioid Analgesia. Anesthesiology 116, 1323-1334.
68. Rittner, H.L., Brack, A., Stein, C., 2008. Pain and the immune system. Br. J. Anaesth. 101, 40-44.
69. Rittner, H.L., Hackel, D., Voigt, P., Mousa, S., Stolz, A., Labuz, D., Schafer, M., Schaefer, M., Stein, C., Brack, A., 2009a. Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog. 5, e1000362.
70. Rittner, H.L., Hackel, D., Yamdeu, R.S., Mousa, S.A., Stein, C., Schäfer, M., Brack, A., 2009b. Antinociception by neutrophil-derived opioid peptides in noninflamed tissue-role of hypertonicity and the perineurium. Brain Behav. Immun. 23, 548-557.
71. Roberts, N.J., Vogelstein, J.T., Parmigiani, G., Kinzler, K.W., Vogelstein, B., Velculescu, V.E., 2012. The predictive capacity of personal genome sequencing. Sci. Transl. Med. 4 133ra158.
72. Roques, B.P., Fournie-Zaluski, M.C., Wurm, M., 2012. Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat. Rev. Drug Discov. 11, 292-310.
73. Ross, J.R., Riley, J., Quigley, C., Welsh, K.I., 2006. Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients. Oncologist 11, 765-773.
74. Rozen, D., Grass, G.W., 2005. Perioperative and intraoperative pain and anesthetic care of the chronic pain and cancer pain patient receiving chronic opioid therapy. Pain Pract. 5, 18-32.
75. Savage, S.R., Joranson, D.E., Covington, E.C., Schnoll, S.H., Heit, H.A., Gilson, A.M., 2003. Definitions related to the medical use of opioids: evolution towards universal agreement. J. Pain Symptom Manage. 26, 655-667.
76. Sawynok, J., 2003. Topical and peripherally acting analgesics. Pharmacol. Rev. 55, 1-20.
77. Schaible, H.G., 2007. Peripheral and central mechanisms of pain generation. Handb. Exp. Pharmacol., 3-28.
78. Schatman, M.E., 2011. The role of the health insurance industry in perpetuating suboptimal pain management. Pain Med. 12, 415-426.
79. Schreiter, A., Gore, C., Labuz, D., Fournie-Zaluski, M.C., Roques, B.P., Stein, C., Machelska, H., 2012. Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue. FASEB J. 26, 5161-5171.
80. Schumacher, M.A., Basbaum, A.I., Way, W.L., 2009. Opioid analgesics and antagonists. In: Katzung, B.G., Masters, S.B., Trevor, A.J. (Eds.), Basic and Clinical Pharmacology. McGraw-Hill Medical, pp. 531-552.
81. Sitte, N., Busch, M., Mousa, S.A., Labuz, D., Rittner, H., Gore, C., Krause, H., Stein, C., Schäfer, M., 2007. Lymphocytes upregulate signal sequence-encoding proopio-melanocortin mRNA and beta-endorphin during painful inflammation in vivo. J. Neuroimmunol. 183, 133-145.
82. Slappendel, R., Weber, E.W., Bugter, M.L., Dirksen, R., 1999. The intensity of preoperative pain is directly correlated with the amount of morphine needed for postoperative analgesia. Anesth. Analg. 88, 146-148.
83. Smith, M.T., 2000. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin. Exp. Pharmacol. Physiol. 27, 524-528.
84. Spahn, V., Fischer, O., Endres-Becker, J., Schäfer, M., Stein, C., Zöllner, C., 2013. Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A dependent manner. Pain 154 (4), 598-608.
85. Stein, A., Yassouridis, A., Szopko, C., Helmke, K., Stein, C., 1999. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83, 525-532.
86. Stein, C., 1993. Peripheral mechanisms of opioid analgesia. Anesth. Analg. 76, 182-191.
87. Stein, C., 1997. Opioid treatment of chronic nonmalignant pain. Anesth. Analg. 84, 912-914.
88. Stein, C., 2012. Towards safer and more effective analgesia. Vet. J., pii:s1090-0233(12) 00398-x. http://dx.doi.org/10.1016/j.tvjl.2012.09.-013. in press. (Epub ahead of print).
89. Stein, C., Comisel, K., Haimerl, E., Yassouridis, A., Lehrberger, K., Herz, A., Peter, K., 1991. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N. Engl. J. Med. 325, 1123-1126.
90. Stein, C., Hassan, A.H., Przewlocki, R., Gramsch, C., Peter, K., Herz, A., 1990. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Nat. Acad. Sci. U.S.A. 87, 5935-5939.
91. Stein, C., Hassan, A.H.S., Lehrberger, K., Giefing, J., Yassouridis, A., 1993. Local analgesic effect of endogenous opioid peptides. Lancet 342, 321-324.
92. Stein, C., Kopf, A., 2013. Anesthesia and treatment of chronic pain. In: Miller, R.D. (Ed.), Miller's Anesthesia, 8th edition Churchill Livingstone, Philadelphia, in press.
93. Stein, C., Küchler, S., 2012. Non-analgesic effects of opioids: peripheral opioid effects on inflammation and wound healing. Curr. Pharm. Des. 18, 6053-6069.
94. Stein, C., Machelska, H., 2011. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol. Rev. 63, 860-881.
95. Stein, C., Pflüger, M., Yassouridis, A., Hoelzl, J., Lehrberger, K., Welte, C., Hassan, A.H. S., 1996. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J. Clin. Invest. 98, 793-799.
96. Stein, C., Reinecke, H., Sorgatz, H., 2010. Opioid use in chronic noncancer pain: guidelines revisited. Curr. Opin. Anaesthesiol. 23, 598-601.
97. Stein, C., Schäfer, M., Machelska, H., 2003. Attacking pain at its source: new perspectives on opioids. Nat. Med. 9, 1003-1008.
98. Tracey, I., Mantyh, P.W., 2007. The cerebral signature for pain perception and its modulation. Neuron 55, 377-391.
99. Vadivelu, N., Mitra, S., Hines, R.L., 2011. Peripheral opioid receptor agonists for analgesia: a comprehensive review. J. Opioid. Manag. 7, 55-68.
100. Valverde, A., Gunkel, C.I., 2005. Pain management in horses and farm animals. J. Vet. Emerg. Crit. Care 15, 295-307.
101. Von Korff, M., Kolodny, A., Deyo, R.A., Chou, R., 2011. Long-term opioid therapy reconsidered. Ann. Intern. Med. 155, 325-328.
102. Von Zastrow, M., 2004. A cell biologist's perspective on physiological adaptation to opiate drugs. Neuropharmacology 47 (Suppl. 1), 286-292.
103. Whiteside, G.T., Adedoyin, A., Leventhal, L., 2008. Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 54, 767-775.
104. Wood, J.N., 2007. Ion channels in analgesia research. Handb. Exp. Pharmacol., 329-358.
105. Woolf, C.J., 2004. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann. Intern. Med. 140, 441-451.
106. Woolf, C.J., 2010. Overcoming obstacles to developing new analgesics. Nat. Med. 16, 1241-1247.
107. Woolf, C.J., Ma, Q., 2007. Nociceptors-noxious stimulus detectors. Neuron 55, 353-364.
108. Zöllner, C., Mousa, S.A., Fischer, O., Rittner, H.L., Shaqura, M., Brack, A., Shakibaei, M., Binder, W., Urban, F., Stein, C., Schäfer, M., 2008. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J. Clin. Invest. 118, 1065-1073.
109. Zöllner, C., Shaqura, M.A., Bopaiah, C.P., Mousa, S.A., Stein, C., Schäfer, M., 2003. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol. Pharmacol. 64, 202-210.
110. Zöllner, C., Stein, C., 2007. Opioids. Handb. Exp. Pharmacol., 31-63.